Prospective comparison of tadalafil 5 mg, dapoxetine 30 mg, and the combination of both in the treatment of premature ejaculation

References

• Tuken M, Culha MG, Serefoglu EC. Efficacy and safety of dapoxetine/sildenafil combination tablets in the treatment of men with premature ejaculation and concomitant erectile dysfunction—DAP-SPEED study. Int J Impot Res. 2019;31(2):92–96. doi: 10.1038/s41443-019-0122-2
   PubMed Web of Science ®Google Scholar
• Serefoglu EC, McMahon CG, Waldinger MD, et al. An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second international society for sexual medicine ad hoc committee for the definition of premature ejaculation. Sex Med. 2014;2(2):41–59. doi: 10.1002/sm2.27
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Desk reference to the diagnostic criteria from DSM-5-TR. Washington, DC: American Psychiatric Association Publishing,; 2022. p. 1. online resource.
   Google Scholar
• Shabsigh R, Rowland D. The diagnostic and Statistical manual of mental disorders, fourth edition, text revision as an appropriate diagnostic for premature ejaculation. J Sex Med. 2007;4(5):1468–1478. doi: 10.1111/j.1743-6109.2007.00557.x
   PubMed Web of Science ®Google Scholar
• Raveendran AV. Premature ejaculation-emerging concepts and a Novel classification. Balkan Med J. 2023 Jul 31;40(6):454–455. Epub. doi: 10.4274/balkanmedj.galenos.2023.2023-6-47
   PubMed Web of Science ®Google Scholar
• Porst H, Montorsi F, Rosen RC, et al. The premature ejaculation prevalence and attitudes (PEPA) survey: prevalence, comorbidities and professional help-seeking. Eur Urol. 2007;51(3):816–824. doi: 10.1016/j.eururo.2006.07.004
   PubMed Web of Science ®Google Scholar
• Moreira ED Jr., Brock G, Glasser DB, et al. Help-seeking behaviour for sexual problems: the global study of sexual attitudes and behaviors. Int J Clin Pract. 2005 Jan;59(1):6–16. doi: 10.1111/j.1742-1241.2005.00382.x
   PubMed Web of Science ®Google Scholar
• Sun Y, Yang L, Bao Y, et al. Efficacy of PDE5Is and SSRIs in men with premature ejaculation: a new systematic review and five meta- analyses. World J Urol. 2017;35(12):1817–1831. doi: 10.1007/s00345-017-2086-5
   PubMed Web of Science ®Google Scholar
• Hatzimouratidis K, Amar E, Eardley I, et al. Guidelines on male sexual dysfunction: Erectile dysfunction and premature ejaculation. Eur Urol. 2010;57(5):804–814. doi: 10.1016/j.eururo.2010.02.020
   PubMed Web of Science ®Google Scholar
• Hellstrom WJ. Emerging treatments for premature ejaculation: Focus on dapoxetine. Neuropsychiatr Dis Treat. 2009;5:37–46. doi: 10.2147/NDT.S3251
   PubMed Web of Science ®Google Scholar
• Waldinger MD, Olivier B. Utility of selective serotonin reuptake inhibitors in premature ejaculation. Curr Opin Invest Drugs. 2004;5(7):743–747.
   PubMedGoogle Scholar
• Abdel-Hamid IA. Phosphodiesterase 5 inhibitors in rapid ejaculation: potential use and possible mechanisms of action. Drugs. 2004;64(1):13–26. doi: 10.2165/00003495-200464010-00002
   PubMed Web of Science ®Google Scholar
• Aversa A, Francomano D, Bruzziches R, et al. Is there a role for phosphodiesterase type-5 inhibitors in the treatment of premature ejaculation? Int J Impot Res. 2011;23(1):17–23. doi: 10.1038/ijir.2010.34
   PubMed Web of Science ®Google Scholar
• Rosen RC, Smith MD, Lipsky J, et al. Development and evaluation of an abridged, 5-item version of the International Index of erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11(6):319–326. doi: 10.1038/sj.ijir.3900472
   PubMed Web of Science ®Google Scholar
• Kim SW, Paick JS. Short-term analysis of the effects of as needed use of sertraline at 5 pm for the treatment of premature ejaculation. Urology. 1999;54(3):544–547. doi: 10.1016/S0090-4295(99)00187-9
   PubMed Web of Science ®Google Scholar
• Gillman N, Gillman M. Premature ejaculation: Aetiology and treatment strategies. Med Sci (Basel). 2019;7(11):102. doi: 10.3390/medsci7110102
   PubMedGoogle Scholar
• Mohseni Rad H, Zahirian Moghadam T, Hosseinkhani A, et al. Comparison of dapoxetine/tadalafil and paroxetine/tadalafil combination therapies for the treatment of the premature ejaculation: a randomized clinical trial. Urol J. 2021 Nov13;19(2):138–143. doi: 10.22037/uj.v18i.6644
   PubMed Web of Science ®Google Scholar
• Moudi E, Kasaeeyan AA. Comparison between tadalafil plus paroxetine and paroxetine alone in the treatment of premature ejaculation. Nephrourol Mon. 2016;8(1):e32286. doi: 10.5812/numonthly.32286
   PubMedGoogle Scholar
• Li J, Liu D, Wu J, et al. Dapoxetine for the treatment of premature ejaculation: a meta-analysis of randomized controlled trials with trial sequential analysis. Ann Saudi Med. 2018;38(5):366–375. doi: 10.5144/0256-4947.2018.366
   PubMed Web of Science ®Google Scholar
• Elbakary M, Elgamasy A, Essa A, et al. A prospective randomized study comparing the efficacy and safety of sildenafil with dapoxetine in treatment of premature ejaculation. Eur Urol Suppl. 2016;15(3):e1000. doi: 10.1016/S1569-9056(16)61001-1
   Google Scholar
• Şentürk AB, Yılmaz AH, Çakıroğlu B, et al. Combination or alone? Which one is the best in premature ejaculation treatment? Spinal Cord. 2020;3:4.
   Google Scholar
• Abu El-Hamd M, Abdelhamed A. Comparison of the clinical efficacy and safety of the on-demand use of paroxetine, dapoxetine, sildenafil and combined dapoxetine with sildenafil in treatment of patients with premature ejaculation: a randomised placebo-controlled clinical trial. Andrologia. 2018;50(1):e12829. doi: 10.1111/and.12829
   Web of Science ®Google Scholar